Advisor Group Holdings, Inc. 9 Meters Biopharma, Inc. Transaction History

Advisor Group Holdings, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$0.26 - $0.64 $1,300 - $3,200	-5,000 Reduced 10.2%	44,000 $10,000
Q1 2022 May 04, 2022	SELL	$0.52 - $1.0 $7,044 - $13,547	-13,547 Reduced 21.66%	49,000 $29,000
Q3 2021 Nov 05, 2021	BUY	$1.03 - $1.41 $29,403 - $40,251	28,547 Added 83.96%	62,547 $81,000
Q2 2021 Aug 02, 2021	BUY	$1.04 - $1.5 $19,760 - $28,500	19,000 Added 126.67%	34,000 $38,000
Q1 2021 May 13, 2021	BUY	$0.84 - $2.16 $12,600 - $32,400	15,000 New	15,000 $18,000

67.9K

Ticker NMTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,955,400
Market Cap $259K
Description
9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders. The company is developing Larazotide, an 8-amino acid peptide, which is in Phase 3 clinical trial for the treatment of celiac disease, as we...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.